SCHEMBL420299

SCHEMBL420299

CCCCCCCCCCCCCC(=O)OC(CCC)C(CCC)OC(=O)CCCCCCCCCCCCC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.66
MAPT P10636 3/20 0.61
MAPK1 P28482 3/20 0.61
ALDH1A1 P00352 1/20 0.58
DGKA P23743 1/20 0.53
PRKCA P17252 1/20 0.53
PRKCE Q02156 1/20 0.53
PRKCQ Q04759 1/20 0.53
PRKCD Q05655 1/20 0.53
CYP1A2 P05177 2/20 0.49
MEN1 O00255 1/20 0.49
GMNN O75496 1/20 0.49
HSP90AA1 P07900 1/20 0.49
BLM P54132 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
TP53 P04637 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28498136 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL427792 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL28499295 1.00 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL425128 0.98 LMNA (0.62) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL10027723 0.96 LMNA (0.61) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL14666490 0.96 LMNA (0.61) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL17965504 0.96 LMNA (0.61) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL14666520 0.92 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL421573 0.92 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA
SCHEMBL14666437 0.92 LMNA (0.66) LMNAMAPTMAPK1ALDH1A1DGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2250241-B1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES CHEVRON USA INC (US) 2016-12-21 EP claimed
EP-2121567-B1 DIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME CHEVRON USA INC (US) 2016-08-10 EP claimed
EP-2992072-A1 DIESTER-BASED BASE OIL BLENDS WITH IMPROVED COLD FLOW PROPERTIES AND LOW NOACK Chevron U.S.A. Inc. (US) 2016-03-09 EP claimed
US-9109238-B2 Synthesis of diester-based lubricants from enzymatically-directed epoxides CHEVRON U.S.A. INC. (US) 2015-08-18 US claimed
US-20150140623-A1 Synthesis of Diester-Based Lubricants from Enzymatically-Directed Epoxides NOVOZYMES A/S (DK) 2015-05-21 US claimed
US-20140342960-A1 BASE OIL BLEND UPGRADING PROCESS WITH A DIESTER BASE OIL TO YIELD IMPROVED COLD FLOW PROPERTIES AND LOW NOACK CHEVRON U.S.A. INC. (US) 2014-11-20 US claimed
US-20140342959-A1 DIESTER-BASED BASE OIL BLENDS WITH IMPROVED COLD FLOW PROPERTIES AND LOW NOACK CHEVRON U.S.A. INC. (US) 2014-11-20 US claimed
US-20140342961-A1 DIESTER-BASED ENGINE OIL FORMULATIONS WITH IMPROVED LOW NOACK AND COLD FLOW PROPERTIES CHEVRON U.S.A. INC. (US) 2014-11-20 US claimed
WO-2014179726-A1 DIESTER-BASED ENGINE OIL FORMULATIONS WITH IMPROVED LOW NOACK AND COLD FLOW PROPERTIES CHEVRON U.S.A. INC. (US) 2014-11-06 WO claimed
WO-2014179723-A1 DIESTER-BASED BASE OIL BLENDS WITH IMPROVED COLD FLOW PROPERTIES AND LOW NOACK CHEVRON U.S.A. INC. (US) 2014-11-06 WO claimed
US-7871967-B2 Diester-based lubricants and methods of making same CHEVRON U.S.A. INC. (US) 2011-01-18 US claimed
US-7867959-B2 Synthesis of diester-based biolubricants from epoxides CHEVRON U.S.A. INC. (US) 2011-01-11 US claimed
EP-2250241-A1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES Chevron U.S.A. Inc. (US) 2010-11-17 EP claimed
WO-2010056832-A2 SYNTHESIS OF DIESTER-BASED LUBRICANTS FROM ENZYMATICALLY-DIRECTED EPOXIDES CHEVRON U.S.A. INC. (US) 2010-05-20 WO claimed
US-20100120642-A1 SYNTHESIS OF DIESTER-BASED LUBRICANTS FROM ENZYMATICALLY-DIRECTED EPOXIDES CHEVRON U.S.A. INC. (US) 2010-05-13 US claimed
EP-2121567-A2 DIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME Chevron U.S.A., Inc. (US) 2009-11-25 EP claimed
US-20090198075-A1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES CHEVRON U.S.A. INC. (US) 2009-08-06 US claimed
WO-2009097041-A1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES CHEVRON U.S.A. INC. (US) 2009-08-06 WO claimed
WO-2008100822-A2 DIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME CHEVRON U.S.A. INC. (US) 2008-08-21 WO claimed
US-20080194444-A1 Diester-Based Lubricants and Methods of Making Same CHEVRON U.S.A. INC. (US) 2008-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150140623-A1 Synthesis of Diester-Based Lubricants from Enzymatically-Directed Epoxides DGAT2, ADH1A, ELOVL1 LMNA 4747/4885MAPT 3281/4885MAPK1 3002/4885
US-20090198075-A1 SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES ELOVL5, ELOVL1, ELOVL3 LMNA 4543/4885MAPT 1348/4885MAPK1 3988/4885
US-20080194444-A1 Diester-Based Lubricants and Methods of Making Same DGAT2, DGAT1, FADS1 LMNA 4799/4885MAPT 2489/4885MAPK1 3615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.